Stephen B Freedman Selected Research

Ondansetron (Zofran)

1/2022	Oral Ondansetron Administration in Children Seeking Emergency Department Care for Acute Gastroenteritis: A Patient-Level Propensity-Matched Analysis.
1/2021	Variables Associated With Intravenous Rehydration and Hospitalization in Children With Acute Gastroenteritis: A Secondary Analysis of 2 Randomized Clinical Trials.
8/2020	A pragmatic randomized controlled trial of multi-dose oral ondansetron for pediatric gastroenteritis (the DOSE-AGE study): statistical analysis plan.
5/2020	Multi-dose Oral Ondansetron for Pediatric Gastroenteritis: study Protocol for the multi-DOSE oral ondansetron for pediatric Acute GastroEnteritis (DOSE-AGE) pragmatic randomized controlled trial.
12/2019	Oral Ondansetron Administration to Dehydrated Children in Pakistan: A Randomized Clinical Trial.
1/2019	Association between ondansetron use and symptom persistence in children with concussions: A 5P substudy.
1/2019	Oral Ondansetron Administration to Nondehydrated Children With Diarrhea and Associated Vomiting in Emergency Departments in Pakistan: A Randomized Controlled Trial.
2/2015	Emergency department ondansetron use in children with type 1 diabetes mellitus and vomiting.
1/2015	Gastroenteritis Therapies in Developed Countries: Systematic Review and Meta-Analysis.
1/2015	Ondansetron and probiotics in the management of pediatric acute gastroenteritis in developed countries.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen B Freedman Research Topics

Disease

28	Gastroenteritis 01/2022 - 04/2006
21	Vomiting 01/2022 - 04/2006
20	Dehydration (Water Stress) 01/2022 - 04/2006
13	Diarrhea 01/2022 - 12/2010
8	Asthma (Bronchial Asthma) 09/2022 - 01/2004
5	Infections 01/2022 - 01/2016
5	Alzheimer Disease (Alzheimer's Disease) 11/2018 - 09/2007
4	Bronchiolitis 01/2020 - 12/2017
3	Hemolytic-Uremic Syndrome 01/2022 - 01/2016
3	Bacterial Meningitis 05/2021 - 12/2010
3	Fever (Fevers) 01/2021 - 01/2020
3	Headache (Headaches) 01/2020 - 12/2018
3	Apnea 01/2020 - 11/2010
3	Weight Gain 05/2015 - 12/2010
2	Respiratory Sounds (Crackle) 09/2022 - 01/2016
2	COVID-19 09/2022 - 01/2022
2	Abdominal Pain (Pain, Abdominal) 01/2022 - 01/2020
2	Brain Concussion (Cerebral Concussion) 01/2022 - 10/2019
2	Sepsis (Septicemia) 11/2021 - 12/2018
2	Wounds and Injuries (Trauma) 08/2021 - 10/2016
2	Pain (Aches) 01/2021 - 12/2018
2	Nausea 11/2020 - 01/2019
2	Constipation 06/2019 - 09/2014
2	Meningitis 01/2019 - 01/2018
2	Multiple Sclerosis 11/2018 - 01/2004
2	Disease Progression 05/2012 - 07/2011
1	Appendicitis 01/2022
1	Panic Disorder (Panic Attack) 01/2022
1	Septic Shock (Toxic Shock Syndrome) 11/2021
1	Bacillary Dysentery (Shigellosis) 10/2021
1	Pharyngitis (Sore Throat) 11/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Post-Concussion Syndrome 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2018
1	Inflammation (Inflammations) 11/2018
1	Neuroinflammatory Diseases 11/2018
1	Central Nervous System Infections (Central Nervous System Infection) 10/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Renal Insufficiency (Renal Failure) 01/2017
1	Weight Loss (Weight Reduction) 05/2016

Drug/Important Bio-Agent (IBA)

18	Ondansetron (Zofran)FDA LinkGeneric 01/2022 - 04/2006
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2010
8	AntiemeticsIBA 10/2020 - 04/2006
6	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2022 - 07/2013
4	Albuterol (Salbutamol)FDA LinkGeneric 01/2021 - 01/2016
4	MagnesiumIBA 01/2021 - 11/2010
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 09/2007
3	ElectrolytesIBA 01/2021 - 05/2016
3	SodiumIBA 10/2020 - 03/2013
3	ZincIBA 12/2019 - 08/2007
2	Nucleic AcidsIBA 09/2022 - 01/2022
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2021
2	Methicillin (Metin)FDA Link 01/2022 - 01/2021
2	Coloring Agents (Dyes)IBA 05/2021 - 01/2020
2	SolutionsIBA 01/2021 - 05/2016
2	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 11/2020 - 01/2016
2	Bicarbonates (Hydrogen Carbonate)IBA 08/2018 - 01/2014
2	Apolipoprotein E4IBA 02/2012 - 02/2011
2	Integrin alpha4beta1 (VLA-4)IBA 03/2011 - 01/2004
2	Amyloid (Amyloid Fibrils)IBA 12/2010 - 09/2007
1	Morphine (MS Contin)FDA LinkGeneric 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	KetorolacIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Saline SolutionIBA 11/2021
1	ChloridesIBA 11/2021
1	Shiga Toxin (Shigella Toxin)IBA 10/2021
1	Rotavirus VaccinesIBA 10/2021
1	RIX4414 vaccineIBA 10/2021
1	VaccinesIBA 10/2021
1	locked nucleic acidIBA 10/2021
1	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2021
1	Secretory Immunoglobulin A (SIgA)IBA 01/2021
1	CreatinineIBA 10/2020
1	insulin receptor-related receptor (IRR)IBA 12/2019
1	Topiramate (Topamax)FDA LinkGeneric 10/2019
1	Amitriptyline (Elavil)FDA LinkGeneric 10/2019
1	Metoclopramide (Reglan)FDA LinkGeneric 12/2018
1	EpitopesIBA 11/2018
1	Monoclonal AntibodiesIBA 11/2018
1	FibrinIBA 11/2018
1	Carbon DioxideIBA 08/2018
1	ORALIT (ORS)IBA 12/2017
1	Indicators and Reagents (Reagents)IBA 01/2017

Therapy/Procedure

22	Fluid Therapy (Oral Rehydration Therapy) 01/2022 - 04/2006
14	Therapeutics 01/2021 - 11/2010
5	Length of Stay 08/2021 - 05/2012
3	Medical Day Care (Partial Hospitalization) 11/2018 - 10/2013
2	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2020 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2019 - 12/2018
1	Resuscitation 11/2021
1	Analgesia 01/2021
1	Appendectomy 01/2020
1	Deprescriptions 01/2019
1	Medication Errors (Medication Error) 12/2018
1	Immunotherapy 11/2018
1	Tracheostomy 01/2017
1	Gastrostomy 01/2017
1	Seat Belts (Seat Belt) 10/2016